Clinical predictors and concomitant antiseizure medications effects on seizure control in relation to plasma cenobamate concentration: a multicenter retrospective study

These findings suggest that CNB may achieve clinically meaningful seizure control at relatively low doses, with variability in plasma concentrations largely influenced by concomitant medications and, to a lesser extent, by individual characteristics. Despite the limited sample size, our results highlight the value of therapeutic drug monitoring and individualized titration to optimize CNB therapy in drug-resistant focal epilepsy.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2025-09-22
DOI
https://doi.org/10.3389/fphar.2025.1668382
Citations
2
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
2.94
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical predictors and concomitant antiseizure medications effects on seizure control in relation to plasma cenobamate concentration: a multicenter retrospective study

Albino Coglianese, Grazia Maria Giovanna Pastorino, Rosaria Renna, Laura Canafoglia et al.
2 citations
Frontiers in Pharmacology
Epilepsy research and treatment
2.94
article

Clinical predictors and concomitant antiseizure medications effects on seizure control in relation to plasma cenobamate concentration: a multicenter retrospective study

Albino Coglianese, Grazia Maria Giovanna Pastorino, Rosaria Renna, Laura Canafoglia, Mariana Fernandes, Antonio Gambardella, Ilaria Sammarra, Antonio Balsamo, Viviana Izzo, Giovanni Assenza, Bruno Charlier, Francesca Felicia Operto, Carlo Di Bonaventura, Mario Tombini, Claudio Liguori, Matteo Antonucci, Marianna Pezzella, Emanuele Cerulli Irelli
article en
2 citations

Abstract

These findings suggest that CNB may achieve clinically meaningful seizure control at relatively low doses, with variability in plasma concentrations largely influenced by concomitant medications and, to a lesser extent, by individual characteristics. Despite the limited sample size, our results highlight the value of therapeutic drug monitoring and individualized titration to optimize CNB therapy in drug-resistant focal epilepsy.

Frontiers in PharmacologyVol. 16
University of Rome Tor Vergata (IT), University of Salerno (IT), Università Campus Bio-Medico (IT), University of Sannio (IT), Magna Graecia University (IT), Ospedale Antonio Cardarelli (IT), Ospedali Riuniti San Giovanni di Dio e Ruggi d'Aragona (IT), Campus Bio Medico University Hospital (IT), Fondazione IRCCS Istituto Neurologico Carlo Besta (IT), Sapienza University of Rome (IT)
Openalex Percentile: Top 8%
Epilepsy research and treatment
2.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.